Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Feb;93(2):862–869. doi: 10.1172/JCI117041

Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression.

C Baudoin 1, C Miquel 1, C Blanchet-Bardon 1, C Gambini 1, G Meneguzzi 1, J P Ortonne 1
PMCID: PMC293950  PMID: 8113417

Abstract

Previous studies have correlated the Herlitz junctional epidermolysis bullosa (H-JEB) to an altered expression of the basement membrane component nicein/kalinin. This heterotrimeric glycoprotein appears to be present in H-JEB tissues in an abnormal form, because a number of antibodies specific to the protein either do not react with or weakly stain the epidermal basement membranes of most of the patients. With cDNA probes encoding each subunit of nicein and polyclonal antibodies raised against bacterial fusion polypeptides corresponding to the individual chains of the protein, we have molecularly analyzed the expression of nicein in H-JEB tissues and cultured keratinocytes. By immunohistochemistry, Northern blot, and protein analysis, we show a defective synthesis of one of the nicein subunits in six cases of H-JEB from five different consanguineous families. In two patients, the disease correlates with an impaired synthesis of the nicein B2 (nic B2) chain, in three others with that of the B1 (nic B1) chain, and in a sixth patient with that of the heavy A (nic A) chain. In this report, we thus demonstrate that H-JEB is a genetically heterogeneous disease and we provide strong evidence that the genes of nicein are the candidates for this genodermatosis.

Full text

PDF
862

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amagai M., Elgart G. W., Klaus-Kovtun V., Stanley J. R. Southern analysis of the 230-kD bullous pemphigoid antigen gene in normal humans, animals, and patients with junctional epidermolysis bullosa. J Invest Dermatol. 1991 Aug;97(2):249–253. doi: 10.1111/1523-1747.ep12480358. [DOI] [PubMed] [Google Scholar]
  2. Carter W. G., Ryan M. C., Gahr P. J. Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell. 1991 May 17;65(4):599–610. doi: 10.1016/0092-8674(91)90092-d. [DOI] [PubMed] [Google Scholar]
  3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  4. Epstein E. H., Jr Molecular genetics of epidermolysis bullosa. Science. 1992 May 8;256(5058):799–804. doi: 10.1126/science.1375393. [DOI] [PubMed] [Google Scholar]
  5. Fine J. D. 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa. Arch Dermatol. 1990 Sep;126(9):1187–1190. [PubMed] [Google Scholar]
  6. Fine J. D., Bauer E. A., Briggaman R. A., Carter D. M., Eady R. A., Esterly N. B., Holbrook K. A., Hurwitz S., Johnson L., Lin A. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol. 1991 Jan;24(1):119–135. doi: 10.1016/0190-9622(91)70021-s. [DOI] [PubMed] [Google Scholar]
  7. Fine J. D., Holbrook K. A., Elias S., Anton-Lamprecht I., Rauskolb R. Applicability of 19-DEJ-1 monoclonal antibody for the prenatal diagnosis or exclusion of junctional epidermolysis bullosa. Prenat Diagn. 1990 Apr;10(4):219–229. doi: 10.1002/pd.1970100403. [DOI] [PubMed] [Google Scholar]
  8. Fine J. D., Horiguchi Y., Jester J., Couchman J. R. Detection and partial characterization of a midlamina lucida-hemidesmosome-associated antigen (19-DEJ-1) present within human skin. J Invest Dermatol. 1989 Jun;92(6):825–830. doi: 10.1111/1523-1747.ep12696839. [DOI] [PubMed] [Google Scholar]
  9. Fuchs E., Coulombe P. A. Of mice and men: genetic skin diseases of keratin. Cell. 1992 Jun 12;69(6):899–902. doi: 10.1016/0092-8674(92)90607-e. [DOI] [PubMed] [Google Scholar]
  10. Garrod D. R. Desmosomes and hemidesmosomes. Curr Opin Cell Biol. 1993 Feb;5(1):30–40. doi: 10.1016/s0955-0674(05)80005-5. [DOI] [PubMed] [Google Scholar]
  11. Heagerty A. H., Kennedy A. R., Eady R. A., Hsi B. L., Verrando P., Yeh C. J., Ortonne J. P. GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa. Lancet. 1986 Apr 12;1(8485):860–860. doi: 10.1016/s0140-6736(86)90972-4. [DOI] [PubMed] [Google Scholar]
  12. Hieda Y., Nishizawa Y., Uematsu J., Owaribe K. Identification of a new hemidesmosomal protein, HD1: a major, high molecular mass component of isolated hemidesmosomes. J Cell Biol. 1992 Mar;116(6):1497–1506. doi: 10.1083/jcb.116.6.1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hopkinson S. B., Riddelle K. S., Jones J. C. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol. 1992 Sep;99(3):264–270. doi: 10.1111/1523-1747.ep12616615. [DOI] [PubMed] [Google Scholar]
  14. Hunter I., Schulthess T., Bruch M., Beck K., Engel J. Evidence for a specific mechanism of laminin assembly. Eur J Biochem. 1990 Mar 10;188(2):205–211. doi: 10.1111/j.1432-1033.1990.tb15391.x. [DOI] [PubMed] [Google Scholar]
  15. Jones J. C., Kurpakus M. A., Cooper H. M., Quaranta V. A function for the integrin alpha 6 beta 4 in the hemidesmosome. Cell Regul. 1991 Jun;2(6):427–438. doi: 10.1091/mbc.2.6.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jonkman M. F., de Jong M. C., Heeres K., Sonnenberg A. Expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa. J Invest Dermatol. 1992 Oct;99(4):489–496. doi: 10.1111/1523-1747.ep12616168. [DOI] [PubMed] [Google Scholar]
  17. Kallunki P., Sainio K., Eddy R., Byers M., Kallunki T., Sariola H., Beck K., Hirvonen H., Shows T. B., Tryggvason K. A truncated laminin chain homologous to the B2 chain: structure, spatial expression, and chromosomal assignment. J Cell Biol. 1992 Nov;119(3):679–693. doi: 10.1083/jcb.119.3.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kurpakus M. A., Jones J. C. A novel hemidesmosomal plaque component: tissue distribution and incorporation into assembling hemidesmosomes in an in vitro model. Exp Cell Res. 1991 May;194(1):139–146. doi: 10.1016/0014-4827(91)90143-i. [DOI] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Marinkovich M. P., Lunstrum G. P., Burgeson R. E. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem. 1992 Sep 5;267(25):17900–17906. [PubMed] [Google Scholar]
  21. Marinkovich M. P., Lunstrum G. P., Keene D. R., Burgeson R. E. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol. 1992 Nov;119(3):695–703. doi: 10.1083/jcb.119.3.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marinkovich M. P., Verrando P., Keene D. R., Meneguzzi G., Lunstrum G. P., Ortonne J. P., Burgeson R. E. Basement membrane proteins kalinin and nicein are structurally and immunologically identical. Lab Invest. 1993 Sep;69(3):295–299. [PubMed] [Google Scholar]
  23. McIntosh I., Hamosh A., Dietz H. C. Nonsense mutations and diminished mRNA levels. Nat Genet. 1993 Jul;4(3):219–219. doi: 10.1038/ng0793-219. [DOI] [PubMed] [Google Scholar]
  24. Meneguzzi G., Marinkovich M. P., Aberdam D., Pisani A., Burgeson R., Ortonne J. P. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp Dermatol. 1992 Dec;1(5):221–229. doi: 10.1111/j.1600-0625.1992.tb00080.x. [DOI] [PubMed] [Google Scholar]
  25. Nazzaro V., Berti E., Cerri A., Brusasco A., Cavalli R., Caputo R. Expression of integrins in junctional and dystrophic epidermolysis bullosa. J Invest Dermatol. 1990 Jul;95(1):60–64. doi: 10.1111/1523-1747.ep12875994. [DOI] [PubMed] [Google Scholar]
  26. Peltz S. W., Jacobson A. mRNA stability: in trans-it. Curr Opin Cell Biol. 1992 Dec;4(6):979–983. doi: 10.1016/0955-0674(92)90129-z. [DOI] [PubMed] [Google Scholar]
  27. Quaranta V., Jones J. C. The internal affairs of an integrin. Trends Cell Biol. 1991 Jul;1(1):2–4. doi: 10.1016/0962-8924(91)90046-c. [DOI] [PubMed] [Google Scholar]
  28. Rheinwald J. G., Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975 Nov;6(3):331–343. doi: 10.1016/s0092-8674(75)80001-8. [DOI] [PubMed] [Google Scholar]
  29. Riddelle K. S., Hopkinson S. B., Jones J. C. Hemidesmosomes in the epithelial cell line 804G: their fate during wound closure, mitosis and drug induced reorganization of the cytoskeleton. J Cell Sci. 1992 Oct;103(Pt 2):475–490. doi: 10.1242/jcs.103.2.475. [DOI] [PubMed] [Google Scholar]
  30. Rousselle P., Lunstrum G. P., Keene D. R., Burgeson R. E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol. 1991 Aug;114(3):567–576. doi: 10.1083/jcb.114.3.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ryynänen M., Knowlton R. G., Kero M., Sawamura D., Li K. H., Giudice G. J., Diaz L. A., Uitto J. Bullous pemphigoid antigens (BPAGs): identification of RFLPs in human BPAG1 and BPAG2, and exclusion as candidate genes in a large kindred with dominant epidermolysis bullosa simplex. Genomics. 1991 Dec;11(4):1025–1029. doi: 10.1016/0888-7543(91)90028-d. [DOI] [PubMed] [Google Scholar]
  32. Ryynänen M., Knowlton R. G., Parente M. G., Chung L. C., Chu M. L., Uitto J. Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa. Am J Hum Genet. 1991 Oct;49(4):797–803. [PMC free article] [PubMed] [Google Scholar]
  33. Sakai L. Y., Keene D. R., Morris N. P., Burgeson R. E. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol. 1986 Oct;103(4):1577–1586. doi: 10.1083/jcb.103.4.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schofield O. M., Fine J. D., Verrando P., Heagerty A. H., Ortonne J. P., Eady R. A. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1078–1083. doi: 10.1016/0190-9622(90)70336-g. [DOI] [PubMed] [Google Scholar]
  35. Schwarz M. A., Owaribe K., Kartenbeck J., Franke W. W. Desmosomes and hemidesmosomes: constitutive molecular components. Annu Rev Cell Biol. 1990;6:461–491. doi: 10.1146/annurev.cb.06.110190.002333. [DOI] [PubMed] [Google Scholar]
  36. Simon M., Green H. Enzymatic cross-linking of involucrin and other proteins by keratinocyte particulates in vitro. Cell. 1985 Mar;40(3):677–683. doi: 10.1016/0092-8674(85)90216-8. [DOI] [PubMed] [Google Scholar]
  37. Sonnenberg A., Calafat J., Janssen H., Daams H., van der Raaij-Helmer L. M., Falcioni R., Kennel S. J., Aplin J. D., Baker J., Loizidou M. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol. 1991 May;113(4):907–917. doi: 10.1083/jcb.113.4.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stepp M. A., Spurr-Michaud S., Tisdale A., Elwell J., Gipson I. K. Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8970–8974. doi: 10.1073/pnas.87.22.8970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tidman M. J., Eady R. A. Hemidesmosome heterogeneity in junctional epidermolysis bullosa revealed by morphometric analysis. J Invest Dermatol. 1986 Jan;86(1):51–56. doi: 10.1111/1523-1747.ep12283807. [DOI] [PubMed] [Google Scholar]
  40. Uitto J., Christiano A. M. Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases. J Clin Invest. 1992 Sep;90(3):687–692. doi: 10.1172/JCI115938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Uitto J., Chung-Honet L. C., Christiano A. M. Molecular biology and pathology of type VII collagen. Exp Dermatol. 1992 Jul;1(1):2–11. doi: 10.1111/j.1600-0625.1992.tb00065.x. [DOI] [PubMed] [Google Scholar]
  42. Verrando P., Blanchet-Bardon C., Pisani A., Thomas L., Cambazard F., Eady R. A., Schofield O., Ortonne J. P. Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest. 1991 Jan;64(1):85–92. [PubMed] [Google Scholar]
  43. Verrando P., Hsi B. L., Yeh C. J., Pisani A., Serieys N., Ortonne J. P. Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res. 1987 May;170(1):116–128. doi: 10.1016/0014-4827(87)90121-2. [DOI] [PubMed] [Google Scholar]
  44. Verrando P., Pisani A., Ortonne J. P. The new basement membrane antigen recognized by the monoclonal antibody GB3 is a large size glycoprotein: modulation of its expression by retinoic acid. Biochim Biophys Acta. 1988 Jul 7;942(1):45–56. doi: 10.1016/0005-2736(88)90273-8. [DOI] [PubMed] [Google Scholar]
  45. Verrando P., Schofield O., Ishida-Yamamoto A., Aberdam D., Partouche O., Eady R. A., Ortonne J. P. Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role. J Invest Dermatol. 1993 Nov;101(5):738–743. doi: 10.1111/1523-1747.ep12371685. [DOI] [PubMed] [Google Scholar]
  46. Wayner E. A., Gil S. G., Murphy G. F., Wilke M. S., Carter W. G. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol. 1993 Jun;121(5):1141–1152. doi: 10.1083/jcb.121.5.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES